Pelvic Inflammatory Disease (PID) News and Research

RSS

Merck, QIAGEN to collaborate to increase access to HPV vaccination and HPV DNA testing in developing countries

Merck & Co., Inc. and QIAGEN N.V. today announced their intent to collaborate on a new program to increase access to HPV vaccination and HPV DNA testing in some of the most resource-poor areas of the world.

From QIAGEN Manchester Limited 24 Sep 2009

Merck's GARDASIL receives approval from FDA Advisory Committee

Merck & Co., Inc. announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee agreed that efficacy, immunogenicity and safety data from clinical trials in males support the use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11.

10 Sep 2009

Image-guided treatment helping women with tubo-ovarian abscesses avoid unnecessary surgery

Image guided drainage of tubo ovarian abscesses help women avoid surgery, according to a study performed at Massachusetts General Hospital in Boston, MA.

23 Apr 2009

Sagent Pharmaceuticals receives FDA approval of Azithromycin for injection

Sagent Pharmaceuticals, Inc. has announced U.S. Food and Drug Administration (FDA) approval of azithromycin for injection, a semi-synthetic, macrolide antibiotic that is used to treat a wide variety of bacterial infections. Sagent will offer azithromycin in a 500 mg vial for intravenous use.

26 Mar 2009

Diagnosis of pelvic inflammatory disease predicts high risk and rate of further infection in teenagers

A study among Baltimore inner-city teenage girls treated for pelvic inflammatory disease shows they are highly vulnerable to subsequent sexually transmitted infections (STI) - sometimes within a few weeks or months of their treatment.

4 Nov 2008

Diagnosis of pelvic inflammatory disease predicts high risk and high rate of further infection in teenagers

3 Nov 2008

Bacterial vaginosis may increase risk of HIV infection

A common vaginal infection may make women more susceptible to contracting HIV, the virus that causes AIDS, University of North Carolina at Chapel Hill School of Public Health researchers have found.

31 Jul 2008

Fourth edition of the British National Formulary for Children

The fourth edition of the British National Formulary for Children (BNFC) arms health professionals with the information they need to tackle recent controversial health concerns in young people, including rising rates of teenage pregnancy and the increasing incidence of sexually transmitted infections.

3 Jul 2008

Roche chlamydia test approved in Europe

Roche has announced that its new test for detection of Chlamydia trachomatis has received CE Mark certification, allowing it to be sold for clinical use in the European Union.

15 Jun 2008

New electronic detection system for infectious illness

Researchers at Harvard Pilgrim Health Care, Harvard Medical School, Atrius Health, and the Massachusetts Department of Public Health have created and tested a set of computer programs that use electronic medical records to help clinicians detect contagious illness and automatically report them to public health departments.

10 Apr 2008

SWHR statement on CDC report on young women and STDs

Society for Women's Health Research President and CEO Phyllis Greenberger, M.S.W., issued the following statement in response to a Centers for Disease Control and Prevention study released yesterday, which found that one in four females aged 14-19 has a sexually transmitted disease:

14 Mar 2008

A quarter of teenage girls in the U.S. have a sex-related disease

The Centers for Disease Control and Prevention (CDC) in the United States has revealed that a quarter of teen girls have a sex-related disease.

11 Mar 2008

Vaginal probiotic product reduce recurrence rate of bacterial vaginosis

A newly published double blind, randomised, placebo controlled study(1) shows that EcoVag, a patented vaginal probiotic product from the Danish company, Bifodan, significantly reduces the recurrence rate of Bacterial Vaginosis (BV) following antibiotic treatment.

31 Jan 2008

Hidden epidemic of sexually transmitted diseases in the U.S.

Health experts in the United States say the country has achieved an all-time record for a sexually transmitted disease.

14 Nov 2007

Intrauterine contraceptive devices are underused in developed countries

Misconceptions around intrauterine contraceptive devices (IUDs) mean that they are underused in developed countries, despite being a safe and effective form of contraception, says a women's health expert in this week's BMJ.

3 Sep 2007

Improved guidelines for providing intrauterine devices

Virginia Commonwealth University researchers have found that intrauterine devices are safe and effective in a population of women previously not considered as good candidates for this method of birth control.

6 Aug 2007

Proactive chlamydia screening does not represent good value for money

Proactive chlamydia screening for young adults is an expensive intervention that probably does not represent good value for money, concludes a study published on bmj.com today.

27 Jul 2007

FDA approves treatment for bacterial vaginosis

Mission Pharmacal has announced that the U.S. Food and Drug Administration (FDA) approved Tindamax (tinidazole) for the treatment of bacterial vaginosis (BV), the most common vaginal infection among women of childbearing age in the United States.

28 May 2007

Search for vaccine to prevent Chlamydia

It's the most common bacteria-related sexually transmitted disease in the United States, so researchers at The University of Texas at San Antonio's South Texas Center for Emerging Infectious Diseases (STCEID) and The University of Texas at San Antonio Health Science Center have partnered to discover a vaccine that will prevent Chlamydia.

19 Feb 2007

Copper containing, framed intra-uterine devices for contraception

Intrauterine devices that contain higher doses of copper are more effective in preventing pregnancy than IUDs with lower copper doses, according to a new systematic review of studies.

19 Jul 2006